Cite
HARVARD Citation
Kim, D. et al. (n.d.). 572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models. Journal for immunotherapy of cancer. p. A344. [Online].